H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. Census population 200,603. Alabama Medicare wound biologics: Palmetto GBA (JJ). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Montgomery clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Montgomery storefront.
Biologic Solutions for Chronic Wounds in Montgomery, AL for clinics & physicians. Biologic solutions for c… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. Obesity 46.4%; arthritis 29.7%. Those three PLACES crude rates (plus Census 200,603) are the local facts on this page. Everything else is the national biologic solutions chronic wounds catalog and JJ paperwork.
National Biologic Solutions for Chronic Wounds notes (how the product actually works)Three grains, kept separate on purpose. City: Census 200,603 and CDC PLACES crude rates. State: Alabama Department of Public Health, Diabetes Belt counties present. Federal: 21 CFR 1271 and Palmetto GBA LCDs. CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the biologic solutions chronic wounds account.
CDC PLACES (2023, crude prevalence) estimates 16.7% of adults — 4.7 points above the U.S. 12% figure. Obesity is 46.4%; arthritis is 29.7%. That is place-level BRFSS modeling, not a clinic census and not a Montgomery trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Alabama.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JJ reviewers and surveyors expect — not a brochure.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Bring specialty, monthly wound volume, and whether you bill JJ FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 16.7% diabetes and 29.7% arthritis for Montgomery — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Montgomery, AL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Montgomery is JJ geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Montgomery — 4.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Alabama Part B wound biologics follow this contractor (siblings: GA, TN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Montgomery. Useful for joint-program math; still needs a diagnosis and privileging.
No Montgomery storefront. Joe Bradley is an active practice owner. biologic solutions chronic wounds stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.